Sort
23,748 grants matching “melanoma”
Genetics of RAS, PTEN, BRAF and CDKN2A in Melanoma
$274,719Philip W Hinds · Tufts Medical Center · R01 · FY2009 · CA
Genetics of RAS, PTEN, BRAF and CDKN2A in Melanoma
$274,719Philip W Hinds · Tufts Medical Center · R01 · FY2007 · CA
Cancer Epigenetics Training Program
$274,719Maria Eugenia Figueroa · University Of Miami School Of Medicine · T32 · FY2021 · CA
Countering immune resistance in the melanoma tumor microenvironment
$274,661Thomas F Gajewski · University Of Chicago · R01 · FY2011 · CA
Melanocyte Survival and Transformation: Hypoxia & P13 Kinase/Akt/mTOR Signaling
$274,609Marianne Broome Powell · Stanford University · R01 · FY2007 · CA
Flow Cytometry Shared Resource (FCSR)
$274,603Zoran Galic · University Of California Los Angeles · P30 · FY2024 · CA
Flow Cytometry Shared Resource (FCSR)
$274,597Zoran Galic · University Of California Los Angeles · P30 · FY2021 · CA
Flow Cytometry Shared Resource (FCSR)
$274,597Zoran Galic · University Of California Los Angeles · P30 · FY2022 · CA
Flow Cytometry Shared Resource (FCSR)
$274,597Zoran Galic · University Of California Los Angeles · P30 · FY2023 · CA
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells
$274,580Niroshana Anandasabapathy · Brigham And Women'S Hospital · R01 · FY2017 · AR
Design of Therapeutic Strategies Specific for Breast Cancer Initiating Cells
$274,523Germana Rappa · University Of South Alabama · R01 · FY2008 · CA
Crosstalk between FceRI and MAVS signaling pathways in mast cells
$274,500Toshiaki Kawakami · La Jolla Institute For Immunology · R21 · FY2020 · AI
ADJUVANT EFFECTS OF ALPHA GALACTOSYLCERAMIDES
$274,500University Of Chicago · R01 · FY2004 · CA
Dysbiosis-induced impairment of tumoral leukocyte extravasation
$274,460Ruud P.m. Dings · Univ Of Arkansas For Med Scis · P20 · FY2017 · GM
Biomarkers
$274,404Janine G Einspahr · University Of Arizona · P01 · FY2011 · CA
Core 2: Animal and Pharmacology
$274,378Jann N Sarkaria · Massachusetts Institute Of Technology · U54 · FY2019 · CA
Nanostructured Cancer Vaccines
$274,364T. Andrew Taton · University Of Minnesota · R01 · FY2009 · CA
POLYNUCLEOTIDE VACCINE STRATEGIES FOR MELANOMA
$274,335University Of Alabama At Birmingham · R01 · FY2001 · CA
Autophagy Modulation for Melanoma Therapy
$274,306Ravi K Amaravadi · Wistar Institute · P50 · FY2016 · CA
Role of NKG2D in immune responses to tumors
$274,268David H Raulet · University Of California Berkeley · R01 · FY2015 · CA
Imaging Nanocomposites Targeting Tumor Microvasculature
$274,182Roswell Park Cancer Institute Corp · R01 · FY2004 · CA
Imaging Nanocomposites Targeting Tumor Microvasculature
$274,182Roswell Park Cancer Institute Corp · R01 · FY2005 · CA
Role of CX3CR1 in the anti-tumor effects of NK cells
$274,120Duke University · R01 · FY2003 · CA
Optimization of MART-1 TCR Gene Transfer for Anti-Melanoma Immunity
$274,100Pin Wang · California Institute Of Technology · P01 · FY2013 · CA
Role of NKG2D in immune responses to tumors
$274,090David H Raulet · University Of California Berkeley · R01 · FY2016 · CA